Overview
- A March 24, 2026 analyst report by Culper Research accused ADMA of using channel stuffing and an undisclosed related‑party distributor, and the stock fell sharply over March 24–25 after the allegations became public.
- The complaints say ADMA inflated 2025 revenue by inducing a distributor to carry excess ASCENIV through rebates and extended payment terms, and they allege the company lacked adequate internal controls.
- Several national plaintiffs' firms have filed or announced class actions and are soliciting investors who bought ADMA stock between August 9, 2024 and March 25, 2026 to seek lead‑plaintiff appointment by the August 10, 2026 deadline.
- The litigation is in early procedural stages, the allegations remain unproven, no class has been certified, and competing firms are positioning to shape case strategy and discovery.
- If a lead plaintiff is appointed, that choice could affect how aggressively the case pursues executive defendants, the scope of document and depositions requests, and the prospects for any recovery for investors who say they lost money.